S100A10 and stroke disorder: Consistent with the results of the latest stroke study, we found that SCI induced the activation of two kinds of astrocytes: neurotoxic A1 astrocytes, which release the neurotoxic complement protein C3d, resulting in neuronal death, and neuroprotective A2 astrocytes, which release S100A10 to protect neurons [4].